DA
ABEV icon

Dunvegan Associates’s Ambev ABEV Stock Holding History

Dunvegan Associates’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-134,693
Closed -$776K – 201
2015
Q1 		$776K Sell
134,693
-4,170
-3% -$25.9K 0.69% 35
2014
Q4 		$864K Sell
138,863
-43,227
-24% -$273K 0.75% 34
2014
Q3 		$1.19M Sell
182,090
-1,580
-0.9% -$11.1K 1.08% 25
2014
Q2 		$1.29M Sell
183,670
-93,600
-34% -$689K 1.08% 27
2014
Q1 		$2.06M Sell
277,270
-3,105
-1% -$21.7K 1.73% 20
2013
Q4 		$2.06M Buy
+280,375
New +$2.05M 1.7% 22

Other funds holding ABEV

VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dunvegan Associates's ABEV Position: Q2 2015 in Review

Dunvegan Associates sold out of Ambev (ABEV) in Q2 2015, closing a stake of 134,693 shares — an estimated $776K sold.

Dunvegan Associates first reported a position in ABEV in Q4 2013 and held it in 6 quarters. The position peaked at $2.06M in Q4 2013. 303 funds tracked by Wall St. Rank hold ABEV as of Q2 2015.

  • Dunvegan Associates reported no remaining Ambev position as of Q2 2015 after selling out during the quarter.
  • Dunvegan Associates sold 134,693 Ambev shares in Q2 2015, an estimated $776K.
  • Dunvegan Associates first reported a position in Ambev in Q4 2013 and held it in 6 quarters.
  • Dunvegan Associates's Ambev position peaked at $2.06M in Q4 2013.
  • 303 funds tracked by Wall St. Rank held Ambev as of Q2 2015.

Based on Dunvegan Associates's 13F filing for Q2 2015, filed 28 Apr 2017.